Valeo Pharma Inc (CSE:VPH) (OTCQB:VPHIF) (FRA:VP2) has completed its negotiations and entered into a letter of intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) regarding Redesca and Redesca HP, its low molecular weight heparin (LMWH) biosimilar, for the prevention and treatment of thromboembolic disord
Full Story >>
Vote
+1